tiprankstipranks
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
FHTX
Foghorn Therapeutics
RESEARCH TOOLSreports
Want to see FHTX full AI Analyst Report?

Foghorn Therapeutics (FHTX) Income Statement

451 Followers

Foghorn Therapeutics Income Statement

Last quarter (Q4 2025), Foghorn Therapeutics's total revenue was $9.25M, an increase of 223.77% from the same quarter last year. In Q4, Foghorn Therapeutics's net income was $-21.66M. See Foghorn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 30.91M$ 22.60M$ 34.16M$ 19.23M$ 1.32M
Gross Profit
$ 27.58M$ 22.60M$ 34.16M$ 19.23M$ 1.32M
Operating Expenses
$ 109.68M$ 125.28M$ 142.06M$ 136.37M$ 102.05M
Depreciation and Amortization
$ 3.33M$ 3.12M$ 3.45M$ 3.32M$ 3.23M
EBITDA
$ -78.78M$ -97.17M$ -104.45M$ -113.82M$ -96.19M
Operating Income
$ -82.11M$ -102.68M$ -107.91M$ -117.14M$ -100.73M
Other Income/Expenses
$ 7.82M$ 16.06M$ 13.71M$ 8.26M$ -586.00K
Pretax Income
$ -74.28M$ -86.62M$ -94.20M$ -108.88M$ -101.32M
Net Income
$ -74.28M$ -86.62M$ -98.43M$ -108.88M$ -101.32M
Per Share Metrics
Basic EPS
$ -1.18$ -1.58$ -2.34$ -2.62$ -2.78
Diluted EPS
$ -1.18$ -1.58$ -2.34$ -2.62$ -2.78
Weighted Average Shares Outstanding
 62.98M 54.90M 41.97M 41.59M 37.17M
Weighted Average Shares Outstanding (Diluted)
 62.98M 54.90M 41.97M 41.59M 37.17M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History